164 results on '"Woodward, David F."'
Search Results
2. Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells
3. The ultra-long lasting intraocular pressure reduction of JV-GL1 is mediated by EP(2) receptors
4. Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract
5. Prostaglandin F(sub 2aplha) formation from prostaglandin H2 by prostaglandin F synthase (PGFS): Crystal structure of PGFS containing bimatoprost
6. The inflow and outflow of anti-glaucoma drugs
7. PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4)
8. The biodisposition and hypertrichotic effects of bimatoprost in mouse skin
9. Bimatoprost and prostaglandin F 2α selectively stimulate intracellular calcium signaling in different cat iris sphincter cells
10. The role of EP2 receptors in mediating the ultra-long-lasting intraocular pressure reduction by JV-GL1.
11. Endogenous bioactive lipids and the regulation of conventional outflow facility
12. Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues
13. Bimatoprost and prostaglandin F2α selectively stimulate intracellular calcium signaling in different cat iris sphincter cells
14. Cellular and Hormonal Regulation of Pigmentation in Human Ocular Melanocytes
15. Investigating the mechanism of long-term intraocular pressure reduction by PGN9856i in mice
16. Vascular Activities of Prostaglandins and Selective Prostanoid Receptor Agonists in Human Retinal Microvessels
17. A Functional Study on Prostanoid Receptors Involved in Cultured Human Iridal Melanocyte Stimulation
18. A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes.
19. Influence of Autonomic Neurotransmitters on Human Uveal Melanocytes in vitro
20. Effect of the Antiglaucoma Agent JV-GL1 and Related Compounds in the Canine Eye.
21. Antiglaucoma EP2 Agonists: A Long Road That Led Somewhere.
22. Chapter 6 - The Pharmacology of Prostaglandin F2α Ethanolamide and Bimatoprost Reveals a Unique Feedback Mechanism on Endocannabinoid Actions
23. Chapter 7 - Prostamide F2α Biosynthesizing Enzymes
24. A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method.
25. In Vivo Choroidal Neovascularization and Macrophage Studies Provide Further Evidence for a Broad Role of Prostacyclin in Angiogenesis.
26. FAAH-Catalyzed C–C Bond Cleavage of a New Multitarget Analgesic Drug.
27. Method for trating pain
28. Different characteristics of postjunctional alpha-adrenoceptors on arterial and venous smooth muscle
29. In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti‐inflammatory effects.
30. Prostanoid Receptor Antagonist Effects on Intraocular Pressure, Supported by Ocular Biodisposition Experiments.
31. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands
32. Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophages.
33. Functional rewiring of G protein-coupled receptor signaling in human labor.
34. Nature of the slow relaxation of smooth muscle induced by a EP2 receptor agonist with a non-prostanoid structure.
35. The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias.
36. Induction of Angiogenic Immediate Early Genes by Activation of FP Prostanoid Receptors in Cultured Human Ciliary Smooth Muscle Cells.
37. Bimatoprost Effects on Aqueous Humor Dynamics in Monkeys.
38. Endogenous bioactive lipids and the regulation of conventional outflow facility.
39. Bimatoprost, a novel efficacious ocular hypotensive drug now recognized as a member of a new class of agents called prostamides.
40. Prostaglandin F2α Formation from Prostaglandin H2 by Prostaglandin F Synthase (PGFS): Crystal Structure of PGFS Containing Bimatoprost.
41. Bimatoprost: Mechanism of Ocular Surface Hyperemia Associated with Topical Therapy.
42. Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription.
43. Upregulation of orphan nuclear receptor Nur77 following PGF2a, Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP2 receptor activated Nur77 gene transcription.
44. Differential Effects of α-Adrenoceptor Agonists on Human Retinal Microvessel Diameter.
45. The distribution of prostamide/prostaglandin F synthase in the developing and adult mouse central nervous system and cultured oligodendrocytes
46. The DP-Receptor Agonist SQ27986 Raises but Does Not Lower Intraocular Pressure in Ocular Normotensive Monkeys.
47. Topical Anti-inflammatory Activity of β2-Adrenoceptor Agonists in the Conjunctiva.
48. Penetration of Natural Prostaglandins and Their Ester Prodrugs and Analogs Across Human Ocular Tissues in Vitro.
49. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
50. AGN 191976: A Novel Thromboxane A2-Mimetic with Ocular Hypotensive Properties.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.